Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Overexpression of a Neuronal Type Adenylyl Cyclase (Type 8) in Sinoatrial Node Markedly Impacts Heart Rate and Rhythm.

Moen JM, Matt MG, Ramirez C, Tarasov KV, Chakir K, Tarasova YS, Lukyanenko Y, Tsutsui K, Monfredi O, Morrell CH, Tagirova S, Yaniv Y, Huynh T, Pacak K, Ahmet I, Lakatta EG.

Front Neurosci. 2019 Jun 18;13:615. doi: 10.3389/fnins.2019.00615. eCollection 2019.

2.

Photocurrent Enhancement by Spontaneous Formation of a p-n Junction in Calcium-Doped Bismuth Vanadate Photoelectrodes.

Abdi FF, Starr DE, Ahmet IY, van de Krol R.

Chempluschem. 2018 Oct;83(10):941-946. doi: 10.1002/cplu.201800119. Epub 2018 May 30.

PMID:
31950613
3.

Tin guanidinato complexes: oxidative control of Sn, SnS, SnSe and SnTe thin film deposition.

Ahmet IY, Hill MS, Raithby PR, Johnson AL.

Dalton Trans. 2018 Apr 3;47(14):5031-5048. doi: 10.1039/C8DT00773J.

PMID:
29561027
4.

Mammalian γ2 AMPK regulates intrinsic heart rate.

Yavari A, Bellahcene M, Bucchi A, Sirenko S, Pinter K, Herring N, Jung JJ, Tarasov KV, Sharpe EJ, Wolfien M, Czibik G, Steeples V, Ghaffari S, Nguyen C, Stockenhuber A, Clair JRS, Rimmbach C, Okamoto Y, Yang D, Wang M, Ziman BD, Moen JM, Riordon DR, Ramirez C, Paina M, Lee J, Zhang J, Ahmet I, Matt MG, Tarasova YS, Baban D, Sahgal N, Lockstone H, Puliyadi R, de Bono J, Siggs OM, Gomes J, Muskett H, Maguire ML, Beglov Y, Kelly M, Dos Santos PPN, Bright NJ, Woods A, Gehmlich K, Isackson H, Douglas G, Ferguson DJP, Schneider JE, Tinker A, Wolkenhauer O, Channon KM, Cornall RJ, Sternick EB, Paterson DJ, Redwood CS, Carling D, Proenza C, David R, Baruscotti M, DiFrancesco D, Lakatta EG, Watkins H, Ashrafian H.

Nat Commun. 2017 Nov 2;8(1):1258. doi: 10.1038/s41467-017-01342-5.

5.

Facile Bulk Synthesis of π-Cubic SnS.

Breternitz J, Gunder R, Hempel H, Binet S, Ahmet I, Schorr S.

Inorg Chem. 2017 Oct 2;56(19):11455-11457. doi: 10.1021/acs.inorgchem.7b01623. Epub 2017 Sep 8.

PMID:
28885013
6.

Long-term low dose dietary resveratrol supplement reduces cardiovascular structural and functional deterioration in chronic heart failure in rats.

Ahmet I, Tae HJ, Lakatta EG, Talan M.

Can J Physiol Pharmacol. 2017 Mar;95(3):268-274. doi: 10.1139/cjpp-2016-0512. Epub 2016 Dec 17.

PMID:
28134561
7.

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics.

Petrasheskaya N, Tae HJ, Ahmet I, Talan MI, Lakatta EG, Lin L.

J Vis Exp. 2016 Sep 19;(115). doi: 10.3791/53777.

8.

Deterioration of autonomic neuronal receptor signaling and mechanisms intrinsic to heart pacemaker cells contribute to age-associated alterations in heart rate variability in vivo.

Yaniv Y, Ahmet I, Tsutsui K, Behar J, Moen JM, Okamoto Y, Guiriba TR, Liu J, Bychkov R, Lakatta EG.

Aging Cell. 2016 Aug;15(4):716-24. doi: 10.1111/acel.12483. Epub 2016 May 10.

9.

Delayed emergence of methamphetamine's enhanced cardiovascular effects in nonhuman primates during protracted methamphetamine abstinence.

Vaupel DB, Schindler CW, Chefer S, Belcher AM, Ahmet I, Scheidweiler KB, Huestis MA, Stein EA.

Drug Alcohol Depend. 2016 Feb 1;159:181-9. doi: 10.1016/j.drugalcdep.2015.12.008. Epub 2015 Dec 24.

10.

Vessel ultrasound sonographic assessment of soluble receptor for advanced glycation end products efficacy in a rat balloon injury model.

Tae HJ, Petrashevskaya N, Ahmet I, Park S, Talan MI, Lakatta EG, Lin L.

Curr Ther Res Clin Exp. 2014 Nov 11;76:110-5. doi: 10.1016/j.curtheres.2014.08.001. eCollection 2014 Dec.

11.

Synchronization of sinoatrial node pacemaker cell clocks and its autonomic modulation impart complexity to heart beating intervals.

Yaniv Y, Ahmet I, Liu J, Lyashkov AE, Guiriba TR, Okamoto Y, Ziman BD, Lakatta EG.

Heart Rhythm. 2014 Jul;11(7):1210-9. doi: 10.1016/j.hrthm.2014.03.049. Epub 2014 Apr 5.

12.

The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth.

Tae HJ, Kim JM, Park S, Tomiya N, Li G, Wei W, Petrashevskaya N, Ahmet I, Pang J, Cruschwitz S, Riebe RA, Zhang Y, Morrell CH, Browe D, Lee YC, Xiao RP, Talan MI, Lakatta EG, Lin L.

J Mol Med (Berl). 2013 Dec;91(12):1369-81. doi: 10.1007/s00109-013-1091-4. Epub 2013 Oct 17.

13.

Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.

Ahmet I, Tae HJ, Brines M, Cerami A, Lakatta EG, Talan MI.

J Pharmacol Exp Ther. 2013 Jun;345(3):446-56. doi: 10.1124/jpet.113.202945. Epub 2013 Apr 12.

14.

Acute hemodynamic effects of erythropoietin do not mediate its cardioprotective properties.

Ahmet I, Lakatta EG, Talan MI.

Biol Open. 2012 Oct 15;1(10):1049-53. doi: 10.1242/bio.20122378. Epub 2012 Aug 22.

15.

Did clinical trials in which erythropoietin failed to reduce acute myocardial infarct size miss a narrow therapeutic window?

Talan MI, Ahmet I, Lakatta EG.

PLoS One. 2012;7(4):e34819. doi: 10.1371/journal.pone.0034819. Epub 2012 Apr 18.

16.

Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.

Ashrafian H, Czibik G, Bellahcene M, Aksentijević D, Smith AC, Mitchell SJ, Dodd MS, Kirwan J, Byrne JJ, Ludwig C, Isackson H, Yavari A, Støttrup NB, Contractor H, Cahill TJ, Sahgal N, Ball DR, Birkler RI, Hargreaves I, Tennant DA, Land J, Lygate CA, Johannsen M, Kharbanda RK, Neubauer S, Redwood C, de Cabo R, Ahmet I, Talan M, Günther UL, Robinson AJ, Viant MR, Pollard PJ, Tyler DJ, Watkins H.

Cell Metab. 2012 Mar 7;15(3):361-71. doi: 10.1016/j.cmet.2012.01.017.

17.

Fenoterol enantiomers do not possess beneficial therapeutic properties of their racemic mixture in the rat model of post myocardial infarction dilated cardiomyopathy.

Ahmet I, Turner T, Lakatta EG, Talan MI.

Cardiovasc Drugs Ther. 2012 Apr;26(2):101-8. doi: 10.1007/s10557-011-6366-9.

18.

Effects of calorie restriction on cardioprotection and cardiovascular health.

Ahmet I, Tae HJ, de Cabo R, Lakatta EG, Talan MI.

J Mol Cell Cardiol. 2011 Aug;51(2):263-71. doi: 10.1016/j.yjmcc.2011.04.015. Epub 2011 May 14.

19.

A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage.

Ahmet I, Tae HJ, Juhaszova M, Riordon DR, Boheler KR, Sollott SJ, Brines M, Cerami A, Lakatta EG, Talan MI.

Mol Med. 2011 Mar-Apr;17(3-4):194-200. doi: 10.2119/molmed.2010.00235. Epub 2010 Dec 16.

20.

Chronic alternate-day fasting results in reduced diastolic compliance and diminished systolic reserve in rats.

Ahmet I, Wan R, Mattson MP, Lakatta EG, Talan MI.

J Card Fail. 2010 Oct;16(10):843-53. doi: 10.1016/j.cardfail.2010.05.007. Epub 2010 Jul 1.

21.

β₂ AR agonists in treatment of chronic heart failure: long path to translation.

Talan MI, Ahmet I, Xiao RP, Lakatta EG.

J Mol Cell Cardiol. 2011 Oct;51(4):529-33. doi: 10.1016/j.yjmcc.2010.09.019. Epub 2010 Oct 1. Review.

22.

Survival and cardioprotective benefits of long-term blueberry enriched diet in dilated cardiomyopathy following myocardial infarction in rats.

Ahmet I, Spangler E, Shukitt-Hale B, Joseph JA, Ingram DK, Talan M.

PLoS One. 2009 Nov 19;4(11):e7975. doi: 10.1371/journal.pone.0007975.

24.

Blueberry-enriched diet protects rat heart from ischemic damage.

Ahmet I, Spangler E, Shukitt-Hale B, Juhaszova M, Sollott SJ, Joseph JA, Ingram DK, Talan M.

PLoS One. 2009 Jun 18;4(6):e5954. doi: 10.1371/journal.pone.0005954.

25.

Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats.

Wan R, Ahmet I, Brown M, Cheng A, Kamimura N, Talan M, Mattson MP.

J Nutr Biochem. 2010 May;21(5):413-7. doi: 10.1016/j.jnutbio.2009.01.020. Epub 2009 May 7.

26.

Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.

Ahmet I, Krawczyk M, Zhu W, Woo AY, Morrell C, Poosala S, Xiao RP, Lakatta EG, Talan MI.

J Pharmacol Exp Ther. 2008 May;325(2):491-9. doi: 10.1124/jpet.107.135335. Epub 2008 Feb 20.

PMID:
18287209
27.

Osteoporosis associated with gyrate atrophy: a case report.

Ahmet I, Serdar KS.

Doc Ophthalmol. 2006 Jul;113(1):61-4. Epub 2006 Aug 12.

PMID:
16906410
29.

Cardioprotection by intermittent fasting in rats.

Ahmet I, Wan R, Mattson MP, Lakatta EG, Talan M.

Circulation. 2005 Nov 15;112(20):3115-21. Epub 2005 Nov 7.

PMID:
16275865
30.

Therapeutic angiogenesis induced by injecting hepatocyte growth factor in ischemic canine hearts.

Yamaguchi T, Sawa Y, Miyamoto Y, Takahashi T, Jau CC, Ahmet I, Nakamura T, Matsuda H.

Surg Today. 2005;35(10):855-60.

PMID:
16175467
31.

Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.

Ahmet I, Krawczyk M, Heller P, Moon C, Lakatta EG, Talan MI.

Circulation. 2004 Aug 31;110(9):1083-90. Epub 2004 Aug 16.

PMID:
15313944
32.

Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats.

Moon C, Krawczyk M, Ahn D, Ahmet I, Paik D, Lakatta EG, Talan MI.

Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11612-7. Epub 2003 Sep 19.

33.

Gene transfer of hepatocyte growth factor improves angiogenesis and function of chronic ischemic myocardium in canine heart.

Ahmet I, Sawa Y, Yamaguchi T, Matsuda H.

Ann Thorac Surg. 2003 Apr;75(4):1283-7.

PMID:
12683576
34.
35.

Myocardial protection using diadenosine tetraphosphate with pharmacological preconditioning.

Ahmet I, Sawa Y, Nishimura M, Yamaguchi T, Kitakaze M, Matsuda H.

Ann Thorac Surg. 2000 Sep;70(3):901-5.

PMID:
11016331
36.

Cardioprotective effect of diadenosine tetraphosphate (AP4A) cardioplegia in isolated rat hearts.

Ahmet I, Sawa Y, Nishimura M, Matsuda H.

Heart Vessels. 2000;15(1):30-4.

PMID:
11001483
37.
38.
39.

Role of endothelial apoptosis in delayed xenograft rejection in pig-to-baboon cardiac transplantation.

Fukushima N, Ohtake S, Yamaguchi T, Kobayashi Y, Yoshitatsu M, Ahmet I, Saito S, Shirakura R, Mastuda H.

Transplant Proc. 1999 Nov;31(7):2731-2. No abstract available.

PMID:
10578268
40.

The effects of a new ultra-short-acting beta-adrenergic blocker, ONO-1101, on cardiac function during and after cardiopulmonary bypass.

Ahmet I, Fukushima N, Sawa Y, Masai T, Kadoba K, Kagisaki K, Chang JC, Yamaguchi T, Matsuda H.

Surg Today. 1999;29(3):248-54.

PMID:
10192736
41.

Prolonged survival of pig cardiac xenografts in baboons by sequential cardiac transplantation.

Fukushima N, Shirakura R, Chang J, Yamaguchi T, Kobayashi Y, Yoshitatsu M, Ahmet I, Saito S, Tsukamoto Y, Matsuda H.

Transplant Proc. 1998 Nov;30(7):3815-7. No abstract available.

PMID:
9838671
42.

Failure of rapid autonomic augmentation of cardiac performance in transplanted hearts.

Fukushima N, Shirakura R, Nakata S, Chang J, Yamaguchi T, Ahmet I, Yoshitatsu M, Kobayashi Y, Matsuda H.

Transplant Proc. 1998 Nov;30(7):3344-6. No abstract available.

PMID:
9838476
43.

Supplemental Content

Support Center